Researchers at the University of Illinois Chicago have identified a molecular switch that helps determine whether cancer cells remain soft and difficult to destroy or become stiff enough for the immune system to attack.
7 hours ago
0
0
Photodynamic therapy (PDT) uses a light-sensitive drug and a specific wavelength of light to destroy cancer cells. The treatment has become an important option for certain skin cancers because it can target diseased tissue ...
8 hours ago
0
3
Viagra was originally developed to treat high blood pressure and chest pain caused by reduced blood flow to the heart, but over the past three decades it has become the world's best-known therapy for erectile dysfunction. ...
12 hours ago
0
9
Chronic, low-grade inflammation in the body—a phenomenon known as "inflammaging" because it increases with age—has been linked to many of today's leading causes of illness and death, including cancer, heart disease, metabolic ...
19 hours ago
0
21
Researchers have uncovered a clue to why immune checkpoint inhibitors—cancer therapies that release the immune "brakes" exploited by tumors to evade attack—show limited efficacy in some brain tumors. A KAIST research team ...
Jul 20, 2026
0
13
One of the biggest challenges in cancer research has been linking the "big picture" seen in medical scans with the microscopic biology that drives tumor growth and dictates how patients respond to treatment. Now, by combining ...
Jul 17, 2026
0
273
A new Northwestern Medicine study has uncovered how a key immunoregulatory receptor plays an unexpected dual role in promoting T-cell exhaustion during chronic infection and cancer, according to findings published in the ...
Jul 16, 2026
0
35
Researchers at the Icahn School of Medicine at Mount Sinai have identified the immune cell that acts as the architect and coordinator of powerful immune hubs that form inside tumors and plays a key role in antitumor immunity. ...
Jul 16, 2026
0
5
Researchers at Kanazawa University report that blood-based gene expression tests may enable early pancreatic cancer screening and improve long-term survival.
Jul 16, 2026
0
14
Researchers at The University of Texas MD Anderson Cancer Center have discovered a new way in which T cells attack acute myeloid leukemia (AML) cells, which may help explain why AML is particularly sensitive to immune-based ...
Jul 16, 2026
0
6
